Clinical Trial Detail

NCT ID NCT03352427
Title Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring PDGFR/FGFR Alterations
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements yes
Sponsors University of Michigan Cancer Center

brain stem glioma

malignant glioma


Dasatinib + Everolimus


Age Groups: child adult

Additional content available in CKB BOOST